Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 76 for “"ketoconazole"”.
-
Topical delivery of different ketoconazole and acyclovir formulations
… Beers, 2006:1061). The anti-fungal agent, ketoconazole, shows activity against the majority of pathogenic fungal infections seen in HIV/AIDS including Candida spp, Cryptocococcus neoformans and Histoplasma capsulatum (Bennet, 2006:1225). Ketoconazole has shown to have in vitro inhibitory …
-
Transdermal delivery of Acyclovir and Ketoconazole by PheroidTM technology
… drug, acyclovir and the antifungal drug, ketoconazole, with the aid of the novel Pheroid™ drug delivery system. Since its appearance in the early 1980's, human immunodeficiency virus (HIV) infection has had a major impact on the field of dermatology. The skin is amongst the organs where …
-
Effects of Ketoconazole on Uterine Weight and on Unbound Serum Estradiol Relative to Vaginal Cornification in Rats
Ketoconazole is a broad-spectrum antifungal with oral activity and is documented to block steroid biosynthesis in fungi and mammals. Estradiol-primed ovariectomized rats lose the estradiol-induced, cornified layer of the vaginal epithelium as a result of ketoconazole treatment. This effect is not …
-
The Effects of Ketoconazole on the Oxidation of Low Density Lipoproteins by Bovine Aortic Smooth Muscle Cells
… This work shows that the azole antifungal drug ketoconazole when added to the culture medium of BASMC inhibits LDL oxidation. Confluent BASMC were fed 1 ml of F- 12/DMEM containing LDL (320 ug protein). The cells over a 24 hour period caused a 2x increase in LDL oxidation as measured by an …
-
Formulation, in vitro release and transdermal diffusion of acyclovir and ketoconazole for skin conditions in HIV/AIDS patients
… of acyclovir (5% w/w), an anti-viral agent and ketoconazole (2% w/w) an anti-fungal agent. The human immununodeficiency virus (HIV) had an immense impact on the spectrum of diagnosis of cutaneous diseases since its first manifestation in the late 1970's (Yen-More et al., 2000:432). The skin is …
-
Hyaluronic Acid Coated Targeted Lipid Micellar Nanoparticle as a Delivery Vehicle for Lapatinib and Ketoconazole in EGFR mutated Lung Cancer
… synthesis and resistance to apoptosis. Ketoconazole is an imidazole antifungal agent which works principally by inhibiting the enzyme cytochrome P450 14α-demethylase (CYP51A1) in the fungal cell membrane. A recent study showed that ketoconazole can reduce cholesterol synthesis in the …
-
Inhibitory Effects of Ketoconazole on the Oxidation of Linoleic Acid Micelles, Phospholipid Liposomes, and Human Low Density Lipoprotein (h-LDL)
… initiator, followed by hematin and SLO. Ketoconazole (KC) attenuated lipid oxidation in a concentration dependent manner at pharmacologically relevant levels (25-100microM) in all three substrates. Pretreatment of liposomes and h-LDL with KC produced greater attenuation of lipid oxidation …
-
In vivo και in vitro εκτίμηση της καθίζησης λιπόφιλων ασθενών βάσεων και του υπερκορεσμού των περιεχομένων του αυλού του λεπτού εντέρου υγιών εν...
… relevant doses of dipyridamole and ketoconazole to twelve fasted healthy adults. Τo develop an in vitro methodology for prediction of concentrations and potential precipitation of highly permeable, lipophilic weak bases in fasted upper small intestine, based on luminal dipyridamole …
-
Immunological Effects of Ketoconazole, Itraconazole and Fluconazole on Lymphocyte Cell Proliferation and Natural Killer Cell Activity in Immune-Normal, Cyclosporine-Compromised and Cyclophosphamide-Compromised Mouse Models
… of this study was to evaluate the effects of Ketoconazole, ltraconazole and Fluconazole on T- and B-cell proliferation and natural killer cell activity using normal, cyclosporine-compromised and cyclophosphamide-compromised immune models in mice. T and B cells obtained from the spleens Balb/c …
-
The effect of the co-administration of the H|2-receptor antagonists on the pharmacokinetics and pharmacodynamics of the H|1-receptor antagonists in rabbits
… and ranitidine, and the antifungal agent ketoconazole, on the pharmacokinetics and pharmacodynamics of the H$\sb1$-receptor antagonist hydroxyzine and its active metabolite cetirizine in rabbits was evaluated by measuring hydroxyzine and cetirizine serum concentrations by HPLC and using …
-
Study of the effects of antifungal agents upon fungi of medical importance
… phases of both yeasts and filamentous fungi. Ketoconazole differed by having significantly higher M. I. C. levels against the test fungi, but was more effective in killing stationary phase cells of Trichophyton mentagrophytes. However, fungicidal activity of ketoconazole against both actively …
-
OXAZOLIDINONES AS A PRIVILEGED SCAFFOLD AND PRELIMINARY EVALUATION
… project outlined in this work, a series of ketoconazole analogs were designed and successfully synthesized. The ketoconazole analogs exhibited antifungal activity; however, no clear trends were observed in this series. Overall, the series exhibited less CYP3A4 inhibition than the parent …
-
Φυσικοχημικά χαρακτηριστικά των περιεχομένων του γαστρεντερικού σωλήνα και η σημασία τους στη διαλυτότητα φαρμάκων
… the assessment of solubility of two weak bases (ketoconazole and dipyridamole) in fasted and fed human aspirates. Twenty healthy volunteers received 250 ml water or 500 ml Ensure plusO (a complete nutrient drink) through a nasogastric tube and samples were aspirated from the antrum of the stomach …
-
Glucocorticoid-Responsive Hepatic Cytochromes P-450 in the Rat: Multiplicity and Differential Regulation
… antifungal drugs clotrimazole, miconazole, or ketoconazole on the expression of three distinct P-450 gene families (glucocorticoid-responsive P-450p, phenobarbital-responsive P-450b/e , and ethanol-responsive P-450j) was determinded by measuring: 1) microsomal enzymatic activities with marker …
-
Targeting Breast Cancer Brain Metastasis Through Novel Combination of FDA-Approved Orally Active Blood-Brain Barrier Permeable RET and tGLI1 Inhibitors
… Pralsetinib in combination with tGLI1 inhibitor Ketoconazole and with WF-229A, a novel Ketoconazole derivative developed by our lab to counter potential liver toxicity due to potent CYP3A4 inhibition by Ketoconazole, yielded synergistic inhibition on BCBM cell viability, induced significantly …
-
Isolation and characterization of echinocandin resistant Candida albicans mutants
… (amphotericin B, 5-flucytosine, fluconazole, ketoconazole), growth, stability, and pharmacodynamic time-kill curves. There were no differences observed between parent and transient mutant strains in antifungal susceptibility, or growth patterns. Transient resistant strains reverted back to the …
-
IN VITRO HEPATIC OXIDATIVE BIOTRANSFORMATION OF TRIMETHOPRIM
… Cα-OH-TMP were formed by CYP3A4 and inhibited by ketoconazole (CYP3A inhibitor). 4'-demethylation was catalyzed by several P450s including CYP3A4, correlated with multiple CYPs, and inhibited primarily with ketoconazole suggesting CYP3A4 contributed to 4'-demethylation. 3-NO-TMP was formed by …
-
Ceratite por Fusarium e outras infecções superficiais no nordeste do Brasil: um estudo prospectivo de 10 anos
… showed increased MICs to amphotericin B and ketoconazole and low MICs to itraconazole. MICs ranged from 0.25 to 16 for amphotericin B, 0.0625 to >16 for ketoconazole and 0.125 to 8 for itraconazole. It is possible to conclude that fusarioid keratitis in Northeastern Brazil is an important and …
-
Lung Cancer Cells Survive EGFR TKI Exposure Through Upregulation of Cholesterol Synthesis
… EGFR TKIs. We then used the CYP51A1 inhibitor, ketoconazole, to downregulate cholesterol synthesis in the cells. The cellular effects of a combination therapy of ketoconazole and EGFR TKI was then studied in parental and DT cells. In both parental and DT cells, ketoconazole and EGFR TKIs acted …
-
Solubility Enhancement and Precipitation Inhibition of Poorly Water Soluble Compounds Utilizing Hot Melt Extrusion Technology
… solid dispersions containing felodipine (FEL) or ketoconazole (KTZ) using hot-melt extrusion technology. The melting point depression approach was utilized to determine the miscibility and solubility of the model compounds within Soluplus® , of which felodipine demonstrated higher solubility when …
Page 1 of 4